Clinical Trial Search

Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants

Primary: Rate of Catheter-associated Urinary Tract Infection — 10; 12 infections per 1000 days

Primary: The Primary Efficacy Outcome of the Study is Response to Treatment Which Will be Assessed at the End of Therapy. Successful Response to Treatment is Defined as…

Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days

Primary: Number of Participants With Appropriate Treatment — 31; 23 Participants — p=0.45

Primary: Microbiological Response at the Test of Cure (TOC) Visit in the Microbiological Modified Intent-to-Treat (mMITT) Population — 83.1; 76.3 percentage of patients

Primary: Participants With Clinically-diagnosed and Treated UTI's. — 15; 30 participants

Primary: Infections Per 1,000 (CAUTI) Days — 0.8429 infection per 1,000 catheter days

Primary: Urinary Tract Infection — 11; 12 UTI

Primary: Occurrence of Symptomatic Urinary Tract Infections (UTIs) — 19; 20; 2; 0 participants — p=0.0383

Primary: Number of Subjects With Combined Clinical and Microbiologic Response — 70 Participants

Primary: The Percentage of Subjects Who Have Both a Per-subject Microbiological Outcome of Eradication and a Clinical Outcome of Cure at the Test of Cure (TOC) Visit in the…

Primary: Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC) — 26; 32; 21; 27 participants

Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97

Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…

Primary: UTI — 15; 14 Participants — p=0.84

Primary: Treatment of Clinically Suspected UTI - Using Intent to Treat Analysis — 13; 12 Participants

Primary: Percentage of Cases Who Received Excessive Post-procedural Antimicrobials — 216; 644 Participants — p=0.004

Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250

Primary: Favorable Clinical Outcomes (FCl) — 170; 132 Participants

Primary: Clinical Response at Test of Cure (TOC) in Microbiological Modified Intent-to-treat (mMITT) Analysis Set — 6; 8; 129; 132 Participant

Primary: Proportion of Asymptomatic Bacteriuria Treated With Antibiotics and Urinary Tract Infection Treated With Antibiotics — 31; 25 Participants

Primary: Extended-Spectrum Days Of Antibacterial Therapy (ES-DOT) Per Empiric Day — 35023; 25987 Extended-Spectrum Days-of-Therapy

Primary: Post-operative Urinary Tract Infection — 19; 20 Participants

Primary: Number of Patients Who Developed Postoperative Urinary Retention (POUR), Unable to Void a Volume Greater Than or Equal to 30ml/hr — 4; 5 Participants

Primary: Urinary Tract Infection Rate — 24; 29 Participants — p=0.30

Primary: Percentage of Participants With Composite Response of Microbiological Eradication and Clinical Response at Test of Cure — 72.6; 54.6 percentage of participants

Primary: Number of Cases of ABU That Are Treated Inappropriately With Antibiotics — 1.6; 0.6; 0.5; 0.6 cases/1,000 bed-days

Primary: Number of Participants With Overall Success — 36; 17 Participants

Primary: Proportion of Participants in the Micro-ITT Population Demonstrating Clinical Cure and Microbiologic Success at the EOI Visit — 363; 382; 51; 7 Participants